MENLO PARK, CA, United States of America

Inkyung Park

This inventor holds 1 USPTO granted patent. Top assignee: Medikine, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inkyung Park. Retrieved from https://idiyas.com/inventor/inkyung-park-bb6kicsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inkyung Park: Innovator in Immunology

Introduction

Inkyung Park is a prominent inventor based in Menlo Park, California. She has made significant contributions to the field of immunology, particularly through her innovative work on IL-7R agonists. Her research has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Inkyung Park holds a patent for IL-7Rαγc ligand immunoglobulin fusion proteins. This patent includes IL-7Rαγc ligands and IL-7Rαγc IgG-Fc fusion proteins, which are disclosed as IL-7R agonists. This innovation represents a significant advancement in the understanding and application of immunological therapies.

Career Highlights

Inkyung Park is associated with Medikine, Inc., where she continues to develop her research and innovations. Her work has garnered attention in the scientific community, showcasing her expertise and dedication to advancing immunological science.

Collaborations

In her career, Inkyung has collaborated with notable professionals such as William J. Dower and Ronald W. Barrett. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Inkyung Park is a trailblazer in the field of immunology, with her innovative work on IL-7R agonists paving the way for future advancements in medical therapies. Her contributions are invaluable to the scientific community and hold promise for improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…